Author

E. Frobert

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:metagenomics· 1 Assay:proteomics· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Bal· 2 shared B. Lina· 2 shared F. Morfin· 2 shared G. Destras· 2 shared G. Queromes· 2 shared L. Josset· 2 shared M. Valette· 2 shared A. Gaymard· 1 shared

Activity by Year

2020-2020 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Bal

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The combination of Bromelain and Acetylcysteine (BromAc) synergistically inactivates SARS-CoV-2

J. Akhter, G. Queromes, K. Pillai, V. Kepenekian, S. Badar, A. Mekkawy, E. Frobert, S. Valle, D. L. Morris

This paper investigates the synergistic effect of Bromelain and Acetylcysteine (BromAc) on SARS-CoV-2, showing it fragments Spike and Envelope proteins and inactivates the virus in vitro.

bioRxiv · Sep 7, 2020 · PreprintMicrobiology

Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France

G. Queromes, G. Destras, A. Bal, H. Regue, G. Burfin, S. Brun, R. Fanget, F. Morfin, M. Valette, B. Lina, E. Frobert, L. Josset

This study identifies two SARS-CoV-2 ORF6 deletion variants from genomic surveillance, showing nosocomial transmission and comparable replication kinetics but no significant clinical impact.

bioRxiv · Aug 7, 2020Microbiology

Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid deletion in nsp2 (Asp268Del)

A. Bal, G. Destras, A. Gaymard, M. Bouscambert-Duchamp, M. Valette, V. Escuret, E. Frobert, G. Billaud, S. Trouillet-Assant, V. Cheynet, K. Brengel-Pesce, F. Morfin, B. Lina, L. Josset

The paper characterizes a SARS-CoV-2 cluster in France, identifying an amino-acid deletion in nsp2 (Asp268Del) present in multiple samples and other European viruses.

bioRxiv · Mar 19, 2020Microbiology